Pembrolizumab shows promise in treatment of mesothelioma – Science Daily

Pembrolizumab shows promise in treatment of mesothelioma
Science Daily
Malignant pleural mesothelioma is a rare and aggressive cancer that represents about 90 percent of all malignant mesothelioma cases. It's primarily caused by the inhalation of asbestos, a fiber commonly found in some forms of insulation, vinyl floor ...

and more »

See more here:

Pembrolizumab shows promise in treatment of mesothelioma - Science Daily

Related Posts

Comments are closed.